Pharma tycoon Murali Divi's Divis Laboratories gets 90% of its $425 million annual revenues from overseas, exporting 100 products from 2 factories in south india, both approved by the U.S. Food & Drug Administration. Half of its business is from custom manufacturing for big pharma companies, the remainder from generics.Fitness fanatic, he has built a yoga center at Divis headquarters in Hyderabad